Related Experiment Video
Updated: Nov 13, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.7K
Rapid Autopsy Programs and Research Support: The Pre- and Post-COVID-19 Environments
1Department of Pathology, The Johns Hopkins University, 600 N. Wolfe Street, Baltimore, MD, 21287, USA.
AJSP: Reviews & Reports
|March 15, 2021
Summary
Rapid autopsies provide valuable tissue samples for research. Adapting these programs for diseases like COVID-19 enhances understanding and public health policy.
Area of Science:
- Pathology
- Medical Research
- Public Health
Background:
- Rapid autopsies (RAPs) are crucial for obtaining timely tissue specimens for researchers.
- The core principle of RAPs is the rapid removal and processing of organs and tissues.
- RAPs require logistical complexity, flexibility, and multidisciplinary collaboration.
Purpose of the Study:
- To highlight the importance of rapid autopsy programs in providing research specimens.
- To discuss the logistical and collaborative aspects essential for successful RAPs.
- To address the challenges and opportunities presented by COVID-19 in autopsy pathology.
Main Methods:
- Emphasizing the need for individualized, broadly applicable consent for postmortem specimens.
- Discussing the adaptation of guidelines for autopsies involving infectious diseases like COVID-19.
- Focusing on the integration of clinical and research efforts in rapid autopsy programs.
Main Results:
- Successful RAPs depend on program flexibility and a multidisciplinary approach.
- Broadly worded consent is vital for utilizing specimens across various diseases and future research.
- COVID-19 has necessitated new protocols, offering unique research opportunities.
Conclusions:
- Rapid autopsy programs are invaluable for medical research, requiring careful planning and collaboration.
- Adapting RAPs to new challenges, such as pandemics, is essential for advancing scientific understanding.
- Autopsy pathology, especially in the context of diseases like COVID-19, significantly contributes to clinical care and public health policy.

